Latest Breaking News On - Thomasr kosten - Page 1 : comparemela.com

Can vaccines, monoclonal antibodies help curb addiction and overdoses?

Can vaccines, monoclonal antibodies help curb addiction and overdoses?
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

White houseDistrict of columbiaUnited statesUniversity of washingtonNorth carolinaKim jandaThomasr kostenAndrewc barrettRyan marinoLittle rockMarco pravetoniAndrewb normanKeith humphreysNora volkowBaylor college of medicineStanford university

The hunt quickens for vaccines and antibody therapies against opioids

The concept has long tantalized scientists: harnessing antibodies to block the dangerous effects of heroin, cocaine and nicotine.

United statesUniversity of washingtonWhite houseDistrict of columbiaNorth carolinaMarco pravetoniNora volkowAndrewc barrettLittle rockRyan marinoAndrewb normanKim jandaThomasr kostenKeith humphreysMedication development for substance use disordersNational institute on drug abuse

The hunt quickens for vaccines and antibody therapies against opioids

Clinical trials are ongoing into a monoclonal antibody treatment for methamphetamine, the stimulant increasingly being used with fentanyl.

United statesUniversity of washingtonNorth carolinaWhite houseDistrict of columbiaRyan marinoAndrewb normanLittle rockNora volkowMarco pravetoniAndrewc barrettThomasr kostenKim jandaKeith humphreysMedication development for substance use disordersIntegrative neurochemistry laboratory at mclean hospital

A New Draft Guide for Developing Stimulant Use Disorder Treatments

The FDA has released a draft guide to offer their perspective and thoughts on the development of treatments for stimulant use disorder.

Baylor college of medicineUnited statesJayh waggonerThomasr kostenJhvephoto adobestockInstitute for clinicalTranslational researchDrug administrationStimulant use disordersDeveloping drugsEndowed chairBaylor collegeStimulant use disorderSubstance use disorderSubstance use

FDA Approves First Naloxone Product for Over-the-Counter Use

The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.

United statesBaylor college of medicineBobby mukkamalaPatrizia cavazzoniTonyp georgeThomasr kostenJayh waggonerUs food drug administrationInstitute for clinicalUniversity of torontoPain care taskAmerican medical associationAmerican college of neuropsychopharmacologyTranslational researchDrug administrationDrug evaluation